Dengue Diagnostics: Current Scenario

Authors

  • Advaita Ganguly Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 11304-89 Avenue, Edmonton, T6G 2N8, Alberta, Canada
  • Ravindra B Malabadi Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 11304-89 Avenue, Edmonton, T6G 2N8, Alberta, Canada
  • Raimer Loebenberg Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 11304-89 Avenue, Edmonton, T6G 2N8, Alberta, Canada
  • Mavanur R Suresh Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 11304-89 Avenue, Edmonton, T6G 2N8, Alberta, Canada
  • Hoon H Sunwoo Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 11304-89 Avenue, Edmonton, T6G 2N8, Alberta, Canada

Keywords:

Dengue hemorrhagic fever, diagnosis, epidemics, PCR based approach, monoclonal antibodies, viral fever, therapy, vaccine

Abstract

There is an urgent requirement for specific, sensitive and inexpensive dengue diagnostic tools that can be used for clinical management, surveillance and outbreak investigations would permit early intervention to treat patients and prevent or control epidemics. Additionally, new techniques for the early detection of severe disease such as the use of biomarkers have the potential to decrease morbidity and mortality. Recent developments in rapid detection technologies offer the promise of improved diagnostics for case management and the early detection of dengue outbreaks. This short review summarizes the various diagnostics tests currently pursued.

Downloads

Download data is not yet available.

Published

21-03-2013

How to Cite

Ganguly, A., B Malabadi, R., Loebenberg, R., R Suresh, M., & H Sunwoo, H. (2013). Dengue Diagnostics: Current Scenario. Research in Biotechnology, 4(2). Retrieved from https://updatepublishing.com/journal/index.php/rib/article/view/2427

Issue

Vol. 4 No. 2 (2013)

Section

Review Article

Most read articles by the same author(s)